natural glp-1 receptor agonists for individualized treatment of type 2 diabetes mellitus Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling:

PMID: 47 MillerWL

[1] [5] While most GLP-1 medications are administered via subcutaneous injection (such as semaglutide, liraglutide, dulaglutide, or tirzepatide), with oral semaglutide (Rybelsus) as the only FDA-approved non-injectable option, transdermal patch delivery systems represent an emerging area of pharmaceutical development

Vi bliver hele tiden klogere p, hvorfor fedmeoperationer har s stor en effekt p bde vgt og sygdomsbillede, og den viden kan vi bruge til at udvikle fremtidens behandlinger til personer med svr overvgt og type 2-diabetes, siger Jens Juul Holst

A well labelled dispensing envelope or medicine pack guides appropriately the patient on how best to take his/her medication